Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Akademische Schlüssel
  • Forschungsbibel
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Zugang zu globaler Online-Forschung in der Landwirtschaft (AGORA)
  • Elektronische Zeitschriftenbibliothek
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • Virtuelle Bibliothek für Biologie (vifabio)
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • ICMJE
Teile diese Seite

Abstrakt

Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment

Lianjie Miao

The current state of healthcare is shifting due to the fast developing field of biotechnology, which has the potential to revolutionize how illnesses are identified and treated. Healthcare biotechnology has been the topic of many great efforts, and our understanding of it has grown significantly. New biomedical paradigms are developing as a result of the most recent developments in genetics and molecular biology, igniting fresh research into brandnew solutions for human health and wellbeing. However, an exciting obstacle still exists in the practical translational development of revolutionary technological discoveries. Only a small number of biotech breakthroughs have led to brand-new, revolutionary treatments and technologies for healthcare. We shall describe the clinical translational development atmosphere for biotechnology in healthcare in this paper. Notable medical biotechnology achievements and translational promotions, including historical findings and novel perspectives are carefully covered. More groundbreaking biotech ideas are about to be translated into commercial products to bring about positive health gains, despite the fact that there are nevertheless numerous obstacles in the bench-to-bedside translational development process. This is being carried out with a tight multitude of collaboration among research institutes, healthcare providers, and industry partners.